Page last updated: 2024-09-03

omega-n-methylarginine and Heart Diseases

omega-n-methylarginine has been researched along with Heart Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atkinson, G; Aziz, NF; Cable, NT; Cuthbertson, DJ; Daousi, C; Green, DJ; Jones, H; Kemp, GJ; Pugh, CJ; Sprung, VS1
Banks, SM; Correa, R; Danner, RL; Eichacker, PQ; Ferantz, V; Gerstenberger, E; Natanson, C; Sevransky, J; Vandivier, RW1
Davies, CH; Harding, SE; Money-Kyrle, AM; Poole-Wilson, PA1
Buikema, H; Crijns, HJ; de Zeeuw, D; Monnink, SH; Tio, RA; van Gilst, WH1
Inoue, S; Ishibashi, Y; Katoh, H; Murakami, Y; Nakamura, K; Ohata, S; Ohta, Y; Sakane, T; Shimada, T; Shimizu, H; Sugamori, T; Takahashi, N1

Trials

1 trial(s) available for omega-n-methylarginine and Heart Diseases

ArticleYear
Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training.
    The Journal of physiology, 2013, Mar-15, Volume: 591, Issue:6

    Topics: Adult; Case-Control Studies; Enzyme Inhibitors; Exercise; Exercise Therapy; Female; Heart Diseases; Heart Function Tests; Hot Temperature; Humans; Insulin Resistance; Laser-Doppler Flowmetry; Lipoproteins, LDL; Microdialysis; Microvessels; Nitric Oxide; omega-N-Methylarginine; Polycystic Ovary Syndrome; Regional Blood Flow; Skin; Vasodilation

2013

Other Studies

4 other study(ies) available for omega-n-methylarginine and Heart Diseases

ArticleYear
Prophylactic high-dose N(omega)-monomethyl-L-arginine prevents the late cardiac dysfunction associated with lethal tumor necrosis factor-alpha challenge in dogs.
    Shock (Augusta, Ga.), 2005, Volume: 23, Issue:3

    Topics: Animals; Blood Pressure; Dogs; Enzyme Inhibitors; Heart Diseases; Heart Rate; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Stroke Volume; Tumor Necrosis Factor-alpha; Vascular Resistance; Ventricular Function, Left

2005
An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart.
    Cardiovascular research, 1998, Volume: 40, Issue:3

    Topics: Adrenergic beta-Agonists; Adult; Aged; Analysis of Variance; Cell Size; Cells, Cultured; Child; Dose-Response Relationship, Drug; Electric Stimulation; Female; Heart Diseases; Humans; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide Synthase; omega-N-Methylarginine; Receptors, Adrenergic, beta

1998
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
    British journal of pharmacology, 2000, Volume: 130, Issue:8

    Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Captopril; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Wistar; Sodium Nitrite; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents

2000
Impaired exercise-induced vasodilatation in chronic atrial fibrillation--role of endothelium-derived nitric oxide.
    Circulation journal : official journal of the Japanese Circulation Society, 2002, Volume: 66, Issue:6

    Topics: Acetylcholine; Adult; Aged; Atrial Fibrillation; Blood Flow Velocity; Chronic Disease; Electric Countershock; Endothelium, Vascular; Female; Forearm; Hand Strength; Heart Diseases; Humans; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Plethysmography; Vasodilation

2002